Open AccessEfficacy and Safety of Linezolid Compared with Vancomycin in a Randomized, Double-Blind Study of Febrile Neutropenic Patients with Cancer
Author(s) -
Branimir Jakšić,
G. Martinelli,
Jaime Pérez de Oteyza,
C. S. Hartman,
Laurence B. Leonard,
Kenneth J. Tack
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/500139
Subject(s) - medicine , linezolid , vancomycin , febrile neutropenia , neutropenia , intensive care medicine , cancer , chemotherapy , staphylococcus aureus , biology , bacteria , genetics
Gram-positive pathogens can cause serious infections in neutropenic patients with cancer, and vancomycin therapy is often initiated empirically. Linezolid may offer an option for these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom